Lasers for lower urinary tract symptoms secondary to benign prostatic hyperplasia: When is the fuss worth it?

Current Urology Reports

Volumn 6, Issue 4, 2005, Pages 257-262

  Hochreiter, Werner W ^a   Müller, Roger M ^b  

^a KLINIK HIRSLANDEN   (Switzerland)

^b NONE

Author keywords

American Urologic Association; Benign Prostatic Hyperplasia; Holmium Laser; Lower Urinary Tract Symptom; Transurethral Resection

Indexed keywords

PHOSPHATE; POTASSIUM TITANYLPHOSPHATE; TITANIUM;

BLADDER OBSTRUCTION; HUMAN; LASER COAGULATION; LASER SURGERY; MALE; MICTURITION DISORDER; PROSTATE; PROSTATE HYPERTROPHY; REVIEW;

HUMANS; LASER COAGULATION; LASER SURGERY; MALE; PHOSPHATES; PROSTATE; PROSTATIC HYPERPLASIA; TITANIUM; URINARY BLADDER NECK OBSTRUCTION; URINATION DISORDERS;

EID: 27744451657     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-005-0018-1     Document Type: Article

References (59)

1. Roehrborn CG, Issa MM, Bruskewitz RC, et al.: Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology 1998, 51:415–421. DOI: 10.1016/S0090-4295(97)00682-1
2. Wheelahan J, Scott NA, Cartmill R, et al.: Minimally invasive laser techniques for prostatectomy: a systematic review. The ASERNIP-S review group. Australian Safety and Efficacy Register of New Interventional Procedures: Surgical. BJU Int 2000, 86:805–815. DOI: 10.1046/j.1464-410x.2000.00920.x
3. Dixon CM: Lasers for the treatment of benign prostatic hyperplasia. Urol Clin North Am 1995, 22:413–422.
4. te Slaa E, de la Rosette JJ: Lasers in the treatment of benign prostatic obstruction: past, present, and future. Eur Urol 1996, 30:1–10.
5. Wasson JH, Reda DJ, Bruskewitz RC, et al.: A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995, 332:75–79. DOI: 10.1056/NEJM199501123320202
6. Horninger W, Unterlechner H, Strasser H, et al.: Transurethral prostatectomy: mortality and morbidity. Prostate 1996, 28:195–200. DOI: 10.1002/(SICI)1097-0045(199603)28:3<195::AID-PROS6>3.0.CO;2-E
7. Oesterling JE: Benign prostatic hyperplasia: medical and minimally invasive treatment options. N Engl J Med 1995, 332:99–109. DOI: 10.1056/NEJM199501123320207
8. Ansari MZ, Costello AJ, Jolley DJ, et al.: Adverse events after prostatectomy in Victorian public hospitals. Aust N Z J Surg 1998, 68:830–836. DOI: 10.1046/j.1440-1622.1998.01466.x
9. Beisland HO, Sander S: First clinical experiences on neodymium YAG laser irradiation of localized prostatic cancer. Scand J Urol Nephrol 1986, 20:113–117.
10. Johnson DE, Price RE, Cromeens DM: Pathologic changes occurring in the prostate following transurethral laser prostatectomy. Lasers Surg Med 1992, 12:254–263. DOI: 10.1002/lsm.1900120304
11. Kandel LB, Harrison LH, McCullough DL, et al.: Transurethral laser prostatectomy in the canine model. Lasers Surg Med 1992, 12:33–42. DOI: 10.1002/lsm.1900120108
12. Costello AJ, Bowsher WG, Bolton DM, et al.: Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 1992, 69:603–608. This paper is the first report of clinical laser prostatectomy. The years that followed were characterized by a worldwide enthusiasm for lasers in the treatment of BPH, particularly for the Nd:YAG device.
13. Narayan P, Tewari A, Aboseif S, et al.: A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia. J Urol 1995, 154:2083–2088. DOI: 10.1016/S0022-5347(01)66701-6
14. Muschter R, Perlmutter AP: The optimization of laser prostatectomy. Part II: other lasing techniques. Urology 1994, 44:856–861. DOI: 10.1016/S0090-4295(94)80170-3
15. Cowles RS III, Kabalin JN, Childs S, et al.: A prospective, randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995, 46:155–160. DOI: 10.1016/S0090-4295(99)80185-X
16. Gerber GS: Lasers in the treatment of benign prostatic hyperplasia. Urology 1995, 45:193–199. DOI: 10.1016/0090-4295(95)80004-2
17. Narayan P, Tewari A, Schalow E, et al.: Transurethral evaporation of the prostate for treatment of benign prostatic hyperplasia: results in 168 patients with up to 12 months of follow-up. J Urol 1997, 157:1309–1312. DOI: 10.1016/S0022-5347(01)64959-0
18. Schatzl G, Madersbacher S, Lang T, et al.: The early postoperative morbidity of transurethral resection of the prostate and of four minimally invasive treatment alternatives. J Urol 1997, 158:105–110. DOI: 10.1097/00005392-199707000-00029
19. Costello AJ, Kabalin JN: Side-firing Neodymium:YAG laser prostatectomy. Eur Urol 1999, 35:138–146. DOI: 10.1159/000019834
20. Anson K, Nawrocki J, Buckley J, et al.: A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995, 46:305–310. DOI: 10.1016/S0090-4295(99)80211-8
21. Kabalin JN, Gill HS, Bite G, et al.: Comparative study of laser versus electrocautery prostatic resection: 18-month followup with complex urodynamic assessment. J Urol 1995, 153:94–98. DOI: 10.1097/00005392-199501000-00033
22. Sengor F, Kose O, Yucebas E, et al.: A comparative study of laser ablation and transurethral electroresection for benign prostatic hyperplasia: results of a 6-month follow-up. Br J Urol 1996, 78:398–400.
23. Keoghane SR, Sullivan ME, Doll HA, et al.: Five-year data from the Oxford Laser Prostatectomy Trial. BJU Int 2000, 86:227–228. DOI: 10.1046/j.1464-410x.2000.00778.x
24. Gujral S, Abrams P, Donovan JL, et al.: A prospective, randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: the CLasP study. J Urol 2000, 164:59–64. DOI: 10.1016/S0022-5347(05)67449-6
25. Shingleton WB, Farabaugh P, May W: Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002, 60:305–308. DOI: 10.1016/S0090-4295(02)01697-7
26. Planz B, Kalem T, Sprenger C, et al.: A prospective, randomized study of combined visual laser ablation and transurethral resection of the prostate versus transurethral prostatectomy alone. Urol Int 2003, 71:26–30. DOI: 10.1159/000071089
27. Perachino M, Puppo P: Prostatectomia laser con metodica sidefire: risultati a distanza di 5 anni. Acta Urol Ital 1998, 12:44. Disappointing 5-year results with unacceptable high retreatment rates.
28. Muschter R, Hofstetter A: Technique and results of interstitial laser coagulation. World J Urol 1995, 13:109–114. DOI: 10.1007/BF00183624
29. Kursh ED, Concepcion R, Chan S, et al.: Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up. Urology 2003, 61:573–578. DOI: 10.1016/S0090-4295(02)02420-2
30. Muschter R, Whitfield H: Interstitial laser therapy of benign prostatic hyperplasia. Eur Urol 1999, 35:147–154. DOI: 10.1159/000019835
31. Norby B, Nielsen HV, Frimodt-Moller PC: Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 2002, 90:853–862. DOI: 10.1046/j.1464-410X.2002.03031.x
32. Malek RS, Barrett DM, Kuntzman RS: High-power potassiumtitanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998, 51:254–256. DOI: 10.1016/S0090-4295(97)00613-4
33. Kuntzman RS, Malek RS, Barrett DM: High-power potassium titanyl phosphate laser vaporization prostatectomy. Mayo Clin Proc 1998, 73:798–801.
34. Kumar SM: Photoselective vaporization of the prostate: a volume-reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol 2005, 173:511–513. DOI: 10.1097/01.ju.0000150099.31289.d7
35. Te AE, Malloy TR, Stein BS, et al.: Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter, prospective trial. J Urol 2004, 172:1404–1408. DOI: 10.1097/01.ju.0000139541.68542.f6
36. Reich O, Bachmann A, Siebels M, et al.: High-power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005, 173:158–160. This most recent report focuses on the efficacy and safety profile of this relatively new technique. DOI: 10.1097/01.ju.0000146631.14200.d4
37. Gilling PJ, Cass CB, Cresswell MD, et al.: Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 1996, 47:48–51. This landmark study assessed the early efficacy and safety of holmium laser resection of the prostate in patients with symptomatic BPH. DOI: 10.1016/S0090-4295(99)80381-1
38. Gilling PJ, Cass CB, Cresswell MD, et al.: The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol 1996, 10:459–461.
39. Gilling PJ, Kennett K, Das AK, et al.: Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol 1998, 12:457–459.
40. Hochreiter W, Hugonnet C, Studer UE: [Transurethral resection of the prostate with the Holmium contact laser: Progress in treatment of benign prostatic hypertrophy?]. Urologe A 1999, 38:156–161. DOI: 10.1007/s001200050260
41. Bukala B, Denstedt JD: Holmium:YAG laser resection of the prostate. J Endourol 1999, 13:215–219.
42. Matsuoka K, Iida S, Tomiyasu K, et al.: Transurethral holmium laser resection of the prostate. J Urol 2000, 163:515–518. DOI: 10.1016/S0022-5347(05)67914-1
43. Moody JA, Lingeman JE: Holmium laser enucleation of the prostate with tissue morcellation: initial United States experience. J Endourol 2000, 14:219–223. DOI: 10.1089/end.2000.14.219
44. Kuntz RM, Fayad A, Lehrich K, et al.: Transurethral holmium laser enucleation of the prostate (HoLEP): a prospective study on 100 patients with one year follow-up. Med Laser Appl 2001, 16:15–22. Noteworthy paper with emphasis on the technical performance. DOI: 10.1078/1615-1615-00004
45. Le Duc A, Gilling PJ: Holmium laser resection of the prostate. Eur Urol 1999, 35:155–160. DOI: 10.1159/000019836
46. Hochreiter WW, Thalmann GN, Burkhard FC, et al.: Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 2002, 168:1470–1474. This report describes an easy-to-do combination of holmium laser enucleation and electrocautery resection to retrieve the resected tissue without compromizing the hemostatic properties of the laser procedure. DOI: 10.1016/S0022-5347(05)64476-X
47. Larizgoitia I, Pons JM: A systematic review of the clinical efficacy and effectiveness of the holmium:YAG laser in urology. BJU Int 1999, 84:1–9. DOI: 10.1046/j.1464-410x.1999.00096.x
48. Fraundorfer MR, Gilling PJ, Kennett KM, et al.: Holmium laser resection of the prostate is more cost effective than transurethral resection of the prostate: results of a randomized prospective study. Urology 2001, 57:454–458. DOI: 10.1016/S0090-4295(00)00987-0
49. Tan AH, Gilling PJ: Holmium laser prostatectomy. BJU Int 2003, 92:527–530. DOI: 10.1046/j.1464-410X.2003.04426.x
50. Tooher R, Sutherland P, Costello A, et al.: A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol 2004, 171:1773–1781. DOI: 10.1097/01.ju.0000113494.03668.6d
51. Gilling PJ, Kennett KM, Fraundorfer MR: Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up. J Endourol 2000, 14:757–760.
52. Gilling PJ, Mackey M, Cresswell M, et al.: Holmium laser versus transurethral resection of the prostate: a randomized, prospective trial with 1-year follow-up. J Urol 1999, 162:1640–1644. DOI: 10.1016/S0022-5347(05)68186-4
53. Kuntz RM, Lehrich K: Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.: a randomized, prospective trial of 120 patients. J Urol 2002, 168:1465–1469. DOI: 10.1016/S0022-5347(05)64475-8
54. Aho TF, Gilling PJ: Laser therapy for benign prostatic hyperplasia: a review of recent developments. Curr Opin Urol 2003, 13:39–44. DOI: 10.1097/00042307-200301000-00007
55. Madersbacher S, Alivizatos G, Nordling J, et al.: EAU 2004 guidelines on assessment, therapy, and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004, 46:547–554. DOI: 10.1016/j.eururo.2004.07.016
56. AUA Practice Guidelines Committee: AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003, 170:530–547. DOI: 10.1097/01.ju.0000078083.38675.79
57. de la Rosette JJ, Alivizatos G, Madersbacher S, et al.: EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2001, 40:256–264. DOI: 10.1159/000049784
58. May F, Hartung R: Surgical treatment of BPH: technique and results. EAU Update Series 2004, 2:15–23. DOI: 10.1016/j.euus.2004.02.001
59. de la Rosette JJ, Gravas S, Muschter R, et al.: Present practice and development of minimally invasive techniques, imaging, and training in European urology: results of a survey of the European Society of Uro-Technology (ESUT). Eur Urol 2003, 44:346–351. DOI: 10.1016/S0302-2838(03)00295-1